| Product Name |
MF |
CAS |
Details |
| OSI-027 |
C21H22N6O3 |
936890-98-1 |
|
| Ruthenium acetylacetonate |
C15H21O6Ru |
14284-93-6 |
|
| (S)-tert-Leucinol |
C6H15NO |
112245-13-3 |
|
| 3,5-Dibromobenzaldehyde |
C7H4Br2O |
56990-02-4 |
|
| Pigment Red 4 |
C16H10ClN3O3 |
2814-77-9 |
|
| 9,9-Bis(4-broMophenyl)fluorene |
C25H16Br2 |
128406-10-0 |
|
| 2,7-Dihydroxy-9-fluorenone |
C13H8O3 |
42523-29-5 |
|
| 3-[(2,2-Dimethyl-1-oxobutyl)thio]propanoic acid methyl ester |
C10H18O3S |
938063-63-9 |
|
| 3-[9-(((3-(N-succiniMidyloxycarboxypropyl)[4-Methxylphenyl]sulfonyl)aMine)carboxyl]-10-acridiniuMyl)-1-propanesulfonate inner salt (NSP-SA-NHS) |
C32H31N3O10S2 |
199293-83-9 |
|
| 3-[9-(((3-(N-succiniMidyloxycarboxypropyl)[4-Methxylphenyl]sulfonyl)aMine)carboxyl]-10-acridiniuMyl)-1-propanesulfonate inner salt (NSP-SA-NHS) |
C32H31N3O10S2 |
199293-83-9 |
|
| alpha-aMine-oMega-propionic acid triethylene glycol |
C9H19NO5 |
784105-33-5 |
|
| 17-Iodoandrosta-5,16-dien-3beta-ol |
C19H27IO |
32138-69-5 |
|
| 17-Iodoandrosta-5,16-dien-3beta-ol |
C19H27IO |
32138-69-5 |
|
| 17-Iodoandrosta-5,16-dien-3beta-ol |
C19H27IO |
32138-69-5 |
|
| 6-BROMO-2-NAPHTHYL-BETA-D-GLUCOPYRANOSIDE |
C16H17BrO6 |
15548-61-5 |
|
| 2-Chloro-8-nitroquinoline |
C9H5ClN2O2 |
4225-86-9 |
|
| 1-Fluoro-cyclopropanecarboxylic acid |
C4H5FO2 |
137081-41-5 |
|
| Ethyl 1-naphthaleneacetate |
C14H14O2 |
2122-70-5 |
|
| (2-Methylbenzo[d]oxazol-6-yl)Methanol |
C9H9NO2 |
136663-40-6 |
|
| Benzeneacetic acid, 4-fluoro-.alpha.-(1-methylethyl)-, (.alpha.S)- |
C13H10F4N2O2 |
830346-47-9 |
|
| (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide |
C19H20N4O |
1038915-64-8 |
|
| Niraparib Tosylate Monohydrate |
C19H20N4O |
1038915-64-8 |
|
| A66 |
C17H23N5O2S2 |
1166227-08-2 |
|
| (5a,11b)-11-[4-(Dimethylamino)phenyl]-5,17-dihydroxy-19-norpregn-9-ene-3,20-dione cyclic bis(1,2-ethanediyl acetal) |
C32H45NO6 |
126690-41-3 |
|
| 5-Bromo-2-chloropyridine-3-carboxamide |
C6H4BrClN2O |
75291-85-9 |
|
| D(-)-allo-Threonine |
C4H9NO3 |
24830-94-2 |
|
| ALLYL A-D-GLUCOPYRANOSIDE |
C9H16O6 |
7464-56-4 |
|
| Pentadecafluorooctanoic acid |
C8HF15O2 |
335-67-1 |
|
| Bumetrizole |
C17H18ClN3O |
3896-11-5 |
|
| 5-((4-BroMo-2,6-difluorophenyl)difluoroMethoxy)-1,2,3-trifluorobenzene |
C13H4BrF7O |
511540-64-0 |
|
| KRN 633 |
C20H21ClN4O4 |
286370-15-8 |
|
| Scandium trifluoromethanesulfonate |
C3F9O9S3Sc |
144026-79-9 |
|
| Scandium trifluoromethanesulfonate |
C3F9O9S3Sc |
144026-79-9 |
|
| 4-Butoxyphenylboronic Acid |
C10H15BO3 |
105365-51-3 |
|
| 4-Butoxyphenylboronic Acid |
C10H15BO3 |
105365-51-3 |
|
| 4,4,5,5-Tetramethyl-2-(perfluorophenyl)-1,3,2-dioxaborolane |
C12H12BF5O2 |
325142-81-2 |
|
| CarbaMic acid, N-[(1S,3S)-3-[4-Methoxy-3-(3-Methoxypropoxy)benzoyl]-4-Methyl-1-[(2S,4S)-tetrahydro-4-(1-Methylethyl)-5-oxo-2-furanyl]pentyl]-, 1,1-diMethylethyl ester |
C30H47NO8 |
934841-22-2 |
|
| 2-Methyl-2-propenoic acid 2-(1-methylethyl)tricyclo[3.3.1.13,7]dec-2-yl ester |
C17H26O2 |
297156-50-4 |
|
| Thioridazine hydrochloride |
C21H27ClN2S2 |
130-61-0 |
|
| Tris(pyrrolidinophosphine) oxide |
C12H24N3OP |
6415-07-2 |
|
| 7-HYDROXYARISTOLOCHIC ACID A |
C16H9NO6 |
475-80-9 |
|
| Apiin |
C26H28O14 |
26544-34-3 |
|
| 6-Chloro-iMidazo[1,2-b]pyridazine-3-carboxylic acid ethyl ester |
C9H8ClN3O2 |
1150566-27-0 |
|
| Gabexate mesylate |
C17H27N3O7S |
56974-61-9 |
|
| (R)-(-)-1-[(S)-2-(DICYCLOHEXYLPHOSPHINO)FERROCENYL]ETHYLDI-T-BUTYLPHOSPHINE |
C32H52FeP2 10* |
158923-11-6 |
|
| PIPERAZINE CITRATE |
C24H46N6O14 |
144-29-6 |
|
| PIPERAZINE CITRATE |
C24H46N6O14 |
144-29-6 |
|
| Sulfogaiacol |
C7H7KO5S |
1321-14-8 |
|
| Sulfogaiacol |
C7H7KO5S |
1321-14-8 |
|
| (3β,25S)-Spirost-5-en-3-yl 6-deoxy-α-L-mannopyranosyl-(1->2)-[β-D-xylopyranosyl-(1->3)]-β-D-glucopyranoside |
C44H70O16 |
87480-46-4 |
|
| 3-Hydroxy-4-methyl-5-ethyl-2(5H)furanone |
C7H10O3 |
698-10-2 |
|
| N1,N1,N2-triMethylethane-1,2-diaMine dihydrochloride |
C5H16Cl2N2 |
326888-32-8 |
|
| Ethanol, 2-[[(3aR,4S,6R,6aS)-6-[[5-aMino-6-chloro-2-(propylthio)-4-pyriMidinyl]aMino]tetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]- |
C17H27ClN4O4S |
376608-74-1 |
|
| 1-Ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole |
C11H19BN2O2 |
1007110-53-3 |
|
| 1-Phenylpyrazole-4-boronic acid |
C9H9BN2O2 |
1201643-70-0 |
|
| DICHLOROQUINOLINE(2,5-) |
C9H5Cl2N |
59412-12-3 |
|
| 1-Bromo-4-butylbenzene |
C10H13Br |
41492-05-1 |
|
| jujuboside B (Compound I) |
C52H84O21 |
68144-21-8 |
|
| (+)-Cloprostenol isopropyl ester |
C25H35ClO6 |
157283-66-4 |
|
| N,N-Dimethylpropionamide |
C5H11NO |
758-96-3 |
|
| (S)-(-)-1,2,3,4-Tetrahedro-naphthoic acid |
C11H12O2 |
85977-52-2 |
|
| (S)-(-)-1,2,3,4-Tetrahedro-naphthoic acid |
C11H12O2 |
85977-52-2 |
|
| (S)-(-)-1,2,3,4-Tetrahedro-naphthoic acid |
C11H12O2 |
85977-52-2 |
|
| N-tert-Butoxycarbonyl-L-glutamic acid gamma-tert-butyl ester |
C14H25NO6 |
13726-84-6 |
|
| 4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-(1,1'-biphenyl)-2-carbonitrile |
C25H27N3O |
138401-24-8 |
|
| 3-Chloroperoxybenzoic acid |
C7H5ClO3 |
937-14-4 |
|
| 1H-Pyrazole, 1-(2-Methylpropyl)-3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)- |
C13H23BN2O2 |
1036757-43-3 |
|
| 1-Cyclohexyl-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole |
C15H25BN2O2 |
1175275-00-9 |
|
| 5-HYDROXY-3,4-DIHYDRO-1H-QUINOLIN-2-ONE |
C9H9NO2 |
30389-33-4 |
|
| (3-CYANOPROPYL)DIMETHYLCHLOROSILANE |
C6H12ClNSi |
18156-15-5 |
|
| Atorvastatin calcium |
C33H37CaFN2O5 |
134523-03-8 |
|
| [(1S,5R,6S)-6-Acetoxy-5-(benzoyloxy)-1-hydroxy-2-oxo-3-cyclohexen-1-yl]methyl benzoate |
C23H20O8 |
358748-29-5 |
|
| 6-broMo-3-fluoropyridine-2-carboxylic acid |
C6H3BrFNO2 |
1052714-48-3 |
|
| 2-octyloxyphenylboronicacid |
C14H23BO3 |
1311163-98-0 |
|
| 2-(4-Hydroxyphenyl)ethyl 6-deoxy-α-L-mannopyranosyl-(1->4)-6-deoxy-α-L-mannopyranosyl-(1->3)-4-O-[(2Z)-3-(4-hydroxyphenyl)-2-propenoyl]-β-D-glucopyranoside |
C35H46O17 |
350588-96-4 |
|
| 1-Hydroxymethyl-5,5-dimethylhydantoin |
C6H10N2O3 |
116-25-6 |
|
| 1-Hydroxymethyl-5,5-dimethylhydantoin |
C6H10N2O3 |
116-25-6 |
|
| OCTADECYL DIISOBUTYL (DIMETHYL AMINO) SILANE |
C28H61NSi |
151613-23-9 |
|
| DL-BETA-PHENYLLACTIC ACID |
C9H10O3 |
828-01-3 |
|
| 4'-FLUORO-2'-METHOXY-5'-ISOPROPYL-4-TRIFLUOROMETHYL-1,1'-BIPHENYL-2-METHANOL |
C18H18F4O2 |
875548-97-3 |
|
| 5-Acetyl-2,4-dimethylthiazole |
C7H9NOS |
38205-60-6 |
|
| Dexamethasone |
C22H29FO5 |
50-02-2 |
|
| Dexamethasone |
C22H29FO5 |
50-02-2 |
|
| Dexamethasone |
C22H29FO5 |
50-02-2 |
|
| 4-Methylbenzophenone |
C14H12O |
134-84-9 |
|
| 2-Bromo-9-phenyl-9H-carbazole |
C18H12BrN |
94994-62-4 |
|
| 2-Bromo-9-phenyl-9H-carbazole |
C18H12BrN |
94994-62-4 |
|
| 5-(N,N-Dibenzylglycyl)salicylamide |
C23H22N2O3 |
30566-92-8 |
|
| 1-Benzyl-3,3-difluoropiperidin-4-one |
C12H13F2NO |
1039741-54-2 |
|
| 4-Benzoylpyridine |
C12H9NO |
14548-46-0 |
|
| 1-(thien-2-yl)cyclopropanecarboxylic acid |
C8H8O2S |
162959-94-6 |
|
| BenzeneMethanol, a-[[[2-(4-aMinophenyl)ethyl]aMino]Methyl]-, (aR)- |
C16H20N2O |
391901-45-4 |
|
| Valdecoxib IMpurity D |
C16H13NO4S |
181696-35-5 |
|
| (S)-2-(1-aMinopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one |
C17H16FN3O |
870281-86-0 |
|
| 5-(4-Bromophenyl)-4,6-dichloropyrimidine |
C10H5BrCl2N2 |
146533-41-7 |
|
| 2-Propenoic acid, 3-(5-nitro-1-cyclohexen-1-yl)-, (2E)- |
C9H11NO4 |
899809-64-4 |
|
| L-Phenylalanine, 4-(2-aMino-6-chloro-4-pyriMidinyl)-N-[(1,1-diMethylethoxy)carbonyl]- |
C18H21ClN4O4 |
1033804-86-2 |
|
| AZD7545 |
C19H18ClF3N2O5S |
252017-04-2 |
|
| 3-oxo-28-norolean-12-ene |
C29H46O |
73493-60-4 |
|
| 3,5-Di-tert-butylsalicylaldehyde |
C15H22O2 |
37942-07-7 |
|
